Published on
June 4, 2022
- 18:07 GMT
Omixon acquires Organ Monitoring Group BV
Omixon to commercialize a cell-free DNA assay for transplant monitoring developed and validated by a transplant physician BUDAPEST, HUNGARY, June 4, 2022 /EINPresswire.com/ -- Omixon Biocomputing, Kft announced today that it has completed a …
Distribution channels:
Banking, Finance & Investment Industry, Chemical Industry
...
